Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn’s disease: results from the BISCUITS study by Frederick Taylor, Giorgio Bartalucci, Catherine Gleave, Liz Dobson, Keith Bodger, Susanna Dodd, Stuart Bloom, Alun Passey, Riikka Nissinen, Daniel Wirth, Andreas Duva, Jennifer Lee, J. R. Fraser Cummings

Get full text